Many adults take acid reflux drugs called proton pump inhibitors for years without needing them. This study looked at how to safely stop or lower these doses. Researchers worked with general practices in western France to test a new approach. They combined a simple brochure for patients with a clear plan sent directly to doctors. This dual approach aimed to help both groups understand when these strong medicines are truly needed. The team involved 1,498 doctors and over 34,000 patients who had used these drugs for at least a year. The goal was to see if this teamwork could change prescribing habits without harming patients. Results showed a clear difference between the new approach and standard care. Patients in the intervention group were much more likely to reduce their medication use. Specifically, nearly 15 percent of patients reduced their dose by half or more. In comparison, only 7 percent of patients in the usual care group achieved this reduction. The doctors who received the plan also adjusted their prescribing more often. This suggests that talking to patients and giving doctors tools works better than just sending letters to doctors alone. The study did not report any safety issues or side effects from stopping the drugs. Patients who lowered their doses did not report worse symptoms on standard scales. This means the change was safe and effective. The findings suggest that simple communication can lead to big changes in how common medicines are used.
Combining patient education with doctor letters cuts acid reflux drug use by nearly 7 percent
Photo by Vitaly Gariev / Unsplash
What this means for you:
Combining patient education with doctor plans safely reduces unnecessary acid reflux drug use. More on Gastroesophageal Reflux Disease
Drug-induced osteoporosis mechanisms and gut microbiota links remain largely unresolved for most medication classes Many common medicines might change gut bacteria and affect bone strength in older adults
Frontiers · Jun 1, 2026
Narrative review of vonoprazan for pediatric H. pylori infection New drug class could simplify hard-to-treat stomach infections in kids
Frontiers · May 13, 2026
Meta-analysis compares total vs partial fundoplication for pediatric GERD Partial Fundoplication Lowers Dysphagia Risk in Children with GERD
· May 6, 2026
GERD Associated with Increased Risk of Laryngeal Cancer in Meta-Analysis Large study links GERD to higher risk of laryngeal cancer
· May 1, 2026